SANTIAGO AND LIMA, (Reuters) - U.S. pharmaceutical company Johnson & Johnson has added Chile, Argentina and Peru to the Latin nations where it plans to conduct Phase III trials for its vaccine against COVID-19, the company confirmed yesterday.
The article J&J adds Chile, Argentina and Peru to Latin America COVID-19 vaccine trials appeared first on Stabroek News.